Prudentia Sciences

Accelerate investment in breakthrough therapies that change the world

Cambridge · Founded 2024 · $27.0M raised

Headquarters
Cambridge
Founded
2024
Business Model
B2B
Total Funding
$27.0M
Last Round
$20.0M Series AJan 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Prudentia Sciences is an AI-native due diligence platform for life sciences dealmaking, founded in 2024 by CEO Sadiqa Mahmood and headquartered in Cambridge, Massachusetts. The company closes the information gap between buyers and sellers before diligence begins, giving pharma and biotech business-development teams a scientific intelligence layer to evaluate assets faster. Prudentia's team includes veterans of Health Catalyst, Moderna, Alexion, and the Broad Institute of Harvard & MIT, backed by scientific and business advisory boards drawn from Ironwood Pharmaceuticals, Eli Lilly, General Atlantic, and Datavant. The company announced $7M in launch funding in January 2025.

Summary

Prudentia Sciences is an Artificial Intelligence company based in Cambridge, founded in 2024. It has raised $27.0M in total across 2 rounds, most recently a $20.0M Series A round in Jan 2026. Investors include GV, McKesson Ventures and Iaso Ventures.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJan 2026
$20.0M

Sign up to see all 2 events

Funding: Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
Lila Sciences

Lila Sciences combines artificial intelligence with autonomous laboratories to accelerate scienti...

Cambridge, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.3BJun 2026
OpenAI

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

San Francisco, United States5001–10000Artificial Intelligence, Generative AI
Corporate RoundTotal funding$179.6BMar 2026
Anthropic

Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...

San Francisco, United States1001–5000Artificial Intelligence, Generative AI
Series G+Total funding$123.7BMay 2026
xAI

xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

San Francisco, United States201–500Artificial Intelligence, Generative AI
Series ETotal funding$47.4BJan 2026
Waymo

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Mountain View, United States1001–5000Artificial Intelligence, Autonomous Vehicles
Venture RoundTotal funding$29.6BFeb 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Prudentia Sciences on Indexed.vc
<a href="https://indexed.vc/companies/prudentia-sciences"><img src="https://indexed.vc/api/badge/company/prudentia-sciences" alt="Prudentia Sciences on Indexed.vc" width="260" height="76" /></a>